Enfusion Other Non Cash Items vs Depreciation Analysis

ENFN Stock

USD 9.94 0.35 3.40%

Enfusion financial indicator trend analysis is much more than just examining Enfusion latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enfusion is a good investment. Please check the relationship between Enfusion Other Non Cash Items and its Depreciation accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.

Other Non Cash Items vs Depreciation

Other Non Cash Items vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Enfusion Other Non Cash Items account and Depreciation. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Enfusion's Other Non Cash Items and Depreciation is 0.96. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of Depreciation in the same time period over historical financial statements of Enfusion, assuming nothing else is changed. The correlation between historical values of Enfusion's Other Non Cash Items and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of Enfusion are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Other Non Cash Items i.e., Enfusion's Other Non Cash Items and Depreciation go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Other Non Cash Items

Depreciation

Depreciation indicates how much of Enfusion value has been used up. For tax purposes Enfusion can deduct the cost of the tangible assets it purchases as business expenses. However, Enfusion must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Most indicators from Enfusion's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enfusion current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.At this time, Enfusion's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 11th of January 2025, Enterprise Value Over EBITDA is likely to grow to 71.41, while Tax Provision is likely to drop about 867 K.

	2022	2023	2024	2025 (projected)
Interest Expense	413K	1.6M	1.9M	2.0M
Depreciation And Amortization	6.6M	10.0M	11.5M	12.1M

Interest Expense Depreciation And Amortization

Enfusion fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital
Total Assets		-0.44	0.86	0.85	0.9	-0.53	0.91	0.85	-0.97	-0.79	-0.86	0.96	0.94	0.86	0.88	0.28	0.9	0.94	0.96	-0.1	-0.84	0.84	0.9	0.95	-0.82	0.95
Short Long Term Debt Total	-0.44		-0.21	-0.27	-0.76	-0.3	-0.75	-0.38	0.55	0.84	0.57	-0.49	-0.45	-0.39	-0.42	-0.14	-0.03	-0.45	-0.39	0.16	0.84	-0.42	-0.43	-0.65	0.86	-0.65
Other Current Liab	0.86	-0.21		0.89	0.76	-0.79	0.78	0.98	-0.88	-0.49	-0.85	0.82	0.72	0.98	0.97	-0.14	0.84	0.72	0.91	0.23	-0.66	0.93	0.69	0.84	-0.63	0.83
Total Current Liabilities	0.85	-0.27	0.89		0.72	-0.52	0.74	0.89	-0.79	-0.48	-0.9	0.77	0.63	0.89	0.88	-0.11	0.79	0.63	0.96	0.42	-0.64	0.92	0.54	0.77	-0.61	0.77
Total Stockholder Equity	0.9	-0.76	0.76	0.72		-0.32	1.0	0.83	-0.96	-0.93	-0.88	0.91	0.87	0.84	0.87	0.18	0.65	0.87	0.86	-0.13	-0.99	0.82	0.84	0.99	-0.98	0.99
Other Liab	-0.53	-0.3	-0.79	-0.52	-0.32		-0.34	-0.68	0.54	0.05	0.41	-0.46	-0.48	-0.68	-0.67	0.13	-0.69	-0.48	-0.53	-0.11	0.19	-0.6	-0.47	-0.45	0.16	-0.44
Net Tangible Assets	0.91	-0.75	0.78	0.74	1.0	-0.34		0.85	-0.96	-0.91	-0.89	0.91	0.86	0.86	0.88	0.15	0.65	0.86	0.86	-0.1	-0.99	0.84	0.83	0.99	-0.98	0.99
Property Plant And Equipment Net	0.85	-0.38	0.98	0.89	0.83	-0.68	0.85		-0.89	-0.57	-0.91	0.82	0.7	1.0	1.0	-0.2	0.74	0.7	0.91	0.28	-0.76	0.97	0.65	0.88	-0.73	0.87
Current Deferred Revenue	-0.97	0.55	-0.88	-0.79	-0.96	0.54	-0.96	-0.89		0.84	0.88	-0.96	-0.93	-0.9	-0.93	-0.19	-0.82	-0.93	-0.92	0.12	0.91	-0.86	-0.9	-0.99	0.89	-0.99
Net Debt	-0.79	0.84	-0.49	-0.48	-0.93	0.05	-0.91	-0.57	0.84		0.7	-0.81	-0.85	-0.58	-0.63	-0.45	-0.5	-0.85	-0.67	0.41	0.95	-0.58	-0.83	-0.88	0.96	-0.89
Retained Earnings	-0.86	0.57	-0.85	-0.9	-0.88	0.41	-0.89	-0.91	0.88	0.7		-0.77	-0.72	-0.91	-0.91	-0.01	-0.64	-0.72	-0.91	-0.18	0.84	-0.97	-0.61	-0.89	0.82	-0.89
Accounts Payable	0.96	-0.49	0.82	0.77	0.91	-0.46	0.91	0.82	-0.96	-0.81	-0.77		0.91	0.83	0.86	0.16	0.86	0.91	0.92	-0.08	-0.86	0.75	0.92	0.94	-0.85	0.94
Cash	0.94	-0.45	0.72	0.63	0.87	-0.48	0.86	0.7	-0.93	-0.85	-0.72	0.91		0.71	0.75	0.51	0.84	1.0	0.82	-0.41	-0.82	0.68	0.98	0.91	-0.81	0.92
Non Current Assets Total	0.86	-0.39	0.98	0.89	0.84	-0.68	0.86	1.0	-0.9	-0.58	-0.91	0.83	0.71		1.0	-0.19	0.74	0.71	0.91	0.27	-0.77	0.97	0.66	0.89	-0.74	0.88
Non Currrent Assets Other	0.88	-0.42	0.97	0.88	0.87	-0.67	0.88	1.0	-0.93	-0.63	-0.91	0.86	0.75	1.0		-0.15	0.76	0.75	0.92	0.21	-0.8	0.95	0.71	0.92	-0.77	0.91
Other Assets	0.28	-0.14	-0.14	-0.11	0.18	0.13	0.15	-0.2	-0.19	-0.45	-0.01	0.16	0.51	-0.19	-0.15		0.25	0.51	0.07	-0.84	-0.19	-0.1	0.46	0.17	-0.2	0.2
Long Term Debt	0.9	-0.03	0.84	0.79	0.65	-0.69	0.65	0.74	-0.82	-0.5	-0.64	0.86	0.84	0.74	0.76	0.25		0.84	0.88	-0.06	-0.54	0.69	0.83	0.74	-0.51	0.75
Cash And Short Term Investments	0.94	-0.45	0.72	0.63	0.87	-0.48	0.86	0.7	-0.93	-0.85	-0.72	0.91	1.0	0.71	0.75	0.51	0.84		0.82	-0.41	-0.82	0.68	0.98	0.91	-0.81	0.92
Net Receivables	0.96	-0.39	0.91	0.96	0.86	-0.53	0.86	0.91	-0.92	-0.67	-0.91	0.92	0.82	0.91	0.92	0.07	0.88	0.82		0.17	-0.79	0.91	0.76	0.9	-0.76	0.9
Common Stock Shares Outstanding	-0.1	0.16	0.23	0.42	-0.13	-0.11	-0.1	0.28	0.12	0.41	-0.18	-0.08	-0.41	0.27	0.21	-0.84	-0.06	-0.41	0.17		0.15	0.27	-0.45	-0.11	0.18	-0.13
Non Current Liabilities Total	-0.84	0.84	-0.66	-0.64	-0.99	0.19	-0.99	-0.76	0.91	0.95	0.84	-0.86	-0.82	-0.77	-0.8	-0.19	-0.54	-0.82	-0.79	0.15		-0.75	-0.79	-0.95	1.0	-0.95
Inventory	0.84	-0.42	0.93	0.92	0.82	-0.6	0.84	0.97	-0.86	-0.58	-0.97	0.75	0.68	0.97	0.95	-0.1	0.69	0.68	0.91	0.27	-0.75		0.58	0.86	-0.72	0.85
Other Current Assets	0.9	-0.43	0.69	0.54	0.84	-0.47	0.83	0.65	-0.9	-0.83	-0.61	0.92	0.98	0.66	0.71	0.46	0.83	0.98	0.76	-0.45	-0.79	0.58		0.87	-0.79	0.88
Other Stockholder Equity	0.95	-0.65	0.84	0.77	0.99	-0.45	0.99	0.88	-0.99	-0.88	-0.89	0.94	0.91	0.89	0.92	0.17	0.74	0.91	0.9	-0.11	-0.95	0.86	0.87		-0.94	1.0
Total Liab	-0.82	0.86	-0.63	-0.61	-0.98	0.16	-0.98	-0.73	0.89	0.96	0.82	-0.85	-0.81	-0.74	-0.77	-0.2	-0.51	-0.81	-0.76	0.18	1.0	-0.72	-0.79	-0.94		-0.94
Net Invested Capital	0.95	-0.65	0.83	0.77	0.99	-0.44	0.99	0.87	-0.99	-0.89	-0.89	0.94	0.92	0.88	0.91	0.2	0.75	0.92	0.9	-0.13	-0.95	0.85	0.88	1.0	-0.94

Click cells to compare fundamentals

Enfusion Account Relationship Matchups

Enfusion fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	39.1M	106.1M	123.8M	109.0M	125.3M	88.2M
Other Current Liab	5.6M	4.4M	7.4M	11.4M	13.2M	13.8M
Total Current Liabilities	10.7M	8.1M	17.4M	20.3M	23.4M	14.2M
Total Stockholder Equity	(233.6M)	55.3M	65.0M	53.7M	61.7M	64.8M
Property Plant And Equipment Net	8.8M	13.1M	22.5M	32.6M	37.5M	39.4M
Net Debt	84.6M	(64.4M)	(55.6M)	(20.2M)	(18.2M)	(17.2M)
Retained Earnings	67.8M	(328K)	(178.9M)	(172.9M)	(155.6M)	(147.9M)
Accounts Payable	484K	2.5M	1.7M	2.2M	2.5M	1.6M
Cash	13.9M	64.4M	62.5M	35.6M	40.9M	40.1M
Non Current Assets Total	10.2M	16.4M	27.0M	39.1M	45.0M	47.2M
Non Currrent Assets Other	1.4M	3.4M	4.5M	6.5M	7.5M	7.9M
Other Assets	1.4M	3.4M	4.5M	1.0	1.15	1.09
Cash And Short Term Investments	13.9M	64.4M	62.5M	35.6M	40.9M	40.1M
Net Receivables	12.2M	18.2M	25.9M	28.1M	32.3M	20.5M
Liabilities And Stockholders Equity	39.1M	106.1M	123.8M	109.0M	125.3M	88.2M
Non Current Liabilities Total	262.0M	538K	3.0M	11.2M	10.1M	9.6M
Other Current Assets	2.8M	13.1M	8.4M	6.2M	7.1M	7.0M
Other Stockholder Equity	(233.3M)	226.7M	244.3M	226.9M	260.9M	274.0M
Total Liab	272.7M	8.6M	20.3M	31.5M	28.3M	26.9M
Net Invested Capital	(135.0M)	55.3M	65.0M	53.7M	61.7M	64.8M
Property Plant And Equipment Gross	13.6M	21.5M	15.8M	49.3M	56.7M	59.6M
Total Current Assets	28.9M	89.7M	96.8M	69.9M	80.3M	66.3M
Accumulated Other Comprehensive Income	(212K)	(171.2M)	(504K)	(406K)	(365.4K)	(383.7K)
Capital Stock	(233.3M)	113K	114K	127K	146.1K	153.4K
Net Working Capital	18.3M	81.6M	79.4M	49.5M	57.0M	52.1M
Common Stock	(233.3M)	113K	114K	127K	146.1K	153.4K

Pair Trading with Enfusion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enfusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enfusion will appreciate offsetting losses from the drop in the long position's value.

Moving together with Enfusion Stock

0.81	DJCO	Daily Journal Corp	Pair Corr
0.91	AI	C3 Ai Inc	Pair Corr
0.82	BL	Blackline	Pair Corr

Moving against Enfusion Stock

0.82	VTEX	VTEX	Pair Corr
0.68	VERB	VERB TECHNOLOGY PANY	Pair Corr
0.38	XELAP	Exela Technologies	Pair Corr
0.32	QH	Quhuo	Pair Corr

The ability to find closely correlated positions to Enfusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enfusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enfusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enfusion to buy it.

The correlation of Enfusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enfusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enfusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Enfusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:

How To Invest In Enfusion

Details

Is Enfusion Stock a good investment?

Details

What is Enfusion's Net Worth?

Details

Largest Application Software Companies

View

Largest Software - Application Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.27)

Earnings Share

0.04

Revenue Per Share

2.155

Quarterly Revenue Growth

0.154

Return On Assets

0.0592

The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enfusion Other Non Cash Items vs Depreciation Analysis

Other Non Cash Items vs Depreciation

Other Non Cash Items vs Depreciation Correlation Analysis

Correlation Coefficient

Other Non Cash Items

Depreciation

Enfusion fundamental ratios Correlations

Enfusion Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enfusion fundamental ratios Accounts

Pair Trading with Enfusion

Moving together with Enfusion Stock

Moving against Enfusion Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Currrent Assets Other	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Non Currrent Assets Other	+ 1.0	Non Current Assets Total
Total Liab	+ 1.0	Non Current Liabilities Total

Net Invested Capital	- 0.99	Current Deferred Revenue
Other Stockholder Equity	- 0.99	Current Deferred Revenue
Non Current Liabilities Total	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Total Liab	- 0.98	Net Tangible Assets
Total Liab	- 0.98	Total Stockholder Equity